— Know what they know.
Not Investment Advice

CRL NYSE

Charles River Laboratories International, Inc.
1W: -0.2% 1M: -14.1% 3M: -6.0% YTD: -21.5% 1Y: +10.7% 3Y: -15.6% 5Y: -51.7%
$160.30
+1.44 (+0.91%)
 
Weekly Expected Move ±8.0%
$127 $139 $151 $163 $175
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 33 · $7.7B mcap · 48M float · 1.91% daily turnover · Short 71% of daily vol

📊 Key Metrics

TTM
$4B
Revenue
+0.1% YoY
$-185M
Net Income
-485.0% YoY
$391M
Free Cash Flow
-30.5% YoY
28.0%
Gross Margin
12.0%
Op. Margin
-1.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-5.6%
ROA-2.5%
ROIC6.2%

Valuation

P/E-42.5
P/B2.7
EV/EBITDA13.2

Leverage

Debt/Equity0.97
Current Ratio1.29
Interest Cov.4.3x

Quality Scores

Piotroski F4/9
Altman Z2.29
Beneish M-2.96

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms